title: Metabolic syndrome and diabetes for the urologist.
abstract: Type 2 diabetes has a number of know urological consequences. Epidemiologic and clinical data suggest a link between metabolic syndrome and prostatic diseases, such as benign prostatic hyperplasia (BPH) and prostate cancer. Recent studies have identified metformin as a viable treatment for patients with type 2 diabetes and prostate cancer.
authors.affiliation: Professor of Surgery and Martin Barkin Chair of Urology, University of Toronto, Head, Division of Urology, University Health Network, Love Chair in Prostate Cancer Prevention, Princess Margaret Hospital, Toronto, ON;
authors.forename: Neil E
authors.initials: NE
authors.lastname: Fleshner
authors.affiliation: Resident in Urology, University of Toronto, Toronto, ON.
authors.forename: Bimal
authors.initials: B
authors.lastname: Bhindi